Evidence map›Paper›PMID 36761157›Full record

ArticleCritical care research and practice2023

Association of Lower Antispike Antibody Levels with Mortality in ICU Patients with COVID-19 Disease.

Sangeeta Yelle, Rahul Amte, Vishwanath Gella, Sasikala Mitnala, Deepika Gujjarlapudi, Mohammed Ismail, Ledo Thankachan, Sandhyarani Adla, Fatima Unnisa, Sivakumar Reddy and 1 more

Abstract read
In one paragraph

Article in Critical care research and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sangeeta YelleCritical Care Medicine, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-2695-0608
Rahul AmteCritical Care Medicine, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-5493-0436
Vishwanath GellaPulmonology, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0003-0866-8999
Sasikala MitnalaResearch Department, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-3785-0530
Deepika GujjarlapudiBiochemistry, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-1806-725X
Mohammed IsmailResearch Department, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-3239-0774
Ledo ThankachanResearch Department, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0002-7949-9304
Sandhyarani AdlaResearch Department, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0001-9375-5303
Fatima UnnisaResearch Department, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0001-7545-6721
Sivakumar ReddyCritical Care Medicine, Asian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0003-3316-6579
Duvvur Nageshwar ReddyAsian Institute of Gastroenterology, Hyderabad, India.ORCID https://orcid.org/0000-0001-7540-0496

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Though vaccines have been reported as highly efficacious in preventing severe COVID-19 disease, there is emerging data of severe infections, albeit a small number, in vaccinated individuals. We have conducted a retrospective observational study to assess the clinical characteristics, immunological response, and disease outcomes among the vaccinated and unvaccinated patients admitted to the ICU with severe COVID-19 disease. Methods: Results: A total of 419 patients with severe COVID-19 were included in the study. Of the 419 patients, 90 (21.5%) were vaccinated, and 329 (78.5%) were unvaccinated. There was a significantly higher mortality in unvaccinated severe COVID 19 patients as compared to vaccinated severe COVID patients (46.2% vs 34.4%; Conclusion: Our study suggests the association of lower neutralizing antibody levels with mortality in ICU patients admitted with COVID-19 breakthrough infections.

Identifiers

PMID36761157
PMCPMC9904915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.